Radiomics Model to Classify Mammary Masses Using Breast DCE-MRI Compared to the BI-RADS Classification Performance
Overview
Authors
Affiliations
Background: Recent advanced in radiomics analysis could help to identify breast cancer among benign mammary masses. The aim was to create a radiomics signature using breast DCE-MRI extracted features to classify tumors and to compare the performances with the BI-RADS classification.
Material And Methods: From September 2017 to December 2019 images, exams and records from consecutive patients with mammary masses on breast DCE-MRI and available histology from one center were retrospectively reviewed (79 patients, 97 masses). Exclusion criterion was malignant uncertainty. The tumors were split in a train-set (70%) and a test-set (30%). From 14 kinetics maps, 89 radiomics features were extracted, for a total of 1246 features per tumor. Feature selection was made using Boruta algorithm, to train a random forest algorithm on the train-set. BI-RADS classification was recorded from two radiologists.
Results: Seventy-seven patients were analyzed with 94 tumors, (71 malignant, 23 benign). Over 1246 features, 17 were selected from eight kinetic maps. On the test-set, the model reaches an AUC = 0.94 95 CI [0.85-1.00] and a specificity of 33% 95 CI [10-70]. There were 43/94 (46%) lesions BI-RADS4 (4a = 12/94 (13%); 4b = 9/94 (10%); and 4c = 22/94 (23%)). The BI-RADS score reached an AUC = 0.84 95 CI [0.73-0.95] and a specificity of 17% 95 CI [3-56]. There was no significant difference between the ROC curves for the model or the BI-RADS score (p = 0.19).
Conclusion: A radiomics signature from features extracted using breast DCE-MRI can reach an AUC of 0.94 on a test-set and could provide as good results as BI-RADS to classify mammary masses.
Wei Z, Iluppangama M, Qi J, Choi J, Yu A, Gage K Cancer Control. 2024; 31:10732748241298539.
PMID: 39545376 PMC: 11565616. DOI: 10.1177/10732748241298539.
Elahi R, Nazari M Radiol Phys Technol. 2024; 17(4):795-818.
PMID: 39285146 DOI: 10.1007/s12194-024-00842-6.
Are we ready to stratify BI-RADS 4 MRI lesions?.
de Oliveira T Radiol Bras. 2024; 56(6):V-VI.
PMID: 38504812 PMC: 10948156. DOI: 10.1590/0100-3984.2023.56.6e1.